Aptose to Present at the Bloom Burton & Co. Healthcare Investor Conference 2019 Apr 24, 2019 7:30am EDT
Aptose To Release First Quarter Ended March 31, 2019 Financial Results and Hold Conference Call on May 7, 2019 Apr 23, 2019 7:30am EDT
Aptose to Present at the H.C. Wainwright Annual Global Life Sciences Conference Apr 02, 2019 7:00am EDT
Aptose Presents New Preclinical Data on CG-806 and APTO-253 at the 2019 AACR Annual Meeting Apr 01, 2019 1:00pm EDT
Aptose Announces FDA Allowance of Investigational New Drug Application for CG-806 Mar 25, 2019 7:02am EDT
Aptose Reports Results for the Fourth Quarter and Year Ended December 31, 2018 Mar 12, 2019 4:02pm EDT
Aptose Biosciences and CrystalGenomics Announce Issuance of Australian Patent for CG-806 Mar 04, 2019 7:00am EST
Aptose to Present New CG-806 and APTO-253 Data at the 2019 AACR Annual Meeting Feb 28, 2019 7:00am EST
Aptose To Release Fourth Quarter and Year End December 31, 2018 Financial Results and Hold Conference Call on March 12, 2019 Feb 26, 2019 7:30am EST
